Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jose Luis Burgos is active.

Publication


Featured researches published by Jose Luis Burgos.


Emerging Infectious Diseases | 2010

Latent Tuberculosis among Persons at Risk for Infection with HIV, Tijuana, Mexico

Richard S. Garfein; Rafael Laniado-Laborín; Timothy C. Rodwell; Remedios Lozada; Robert Deiss; Jose Luis Burgos; Jazmine Cuevas-Mota; Paris Cerecer; Kathleen Moser; Maria Luisa Volker; Steffanie A. Strathdee

Interventions that prevent HIV transmission and TB reactivation are needed.


American Journal of Public Health | 2009

Influences of Cross-Border Mobility on Tuberculosis Diagnoses and Treatment Interruption Among Injection Drug Users in Tijuana, Mexico

Robert Deiss; Richard S. Garfein; Remedios Lozada; Jose Luis Burgos; Kimberly C. Brouwer; Kathleen Moser; María Luisa Zúñiga; Timothy C. Rodwell; Victoria D. Ojeda; Steffanie A. Strathdee

OBJECTIVES We sought to identify correlates of reported lifetime diagnoses of TB among injection drug users in the border city of Tijuana, Mexico. METHODS Injection drug users in Tijuana were recruited into a prospective cohort study during 2006 and 2007. We used weighted multivariate logistic regression to identify correlates of TB diagnoses. RESULTS Of the 1056 participants, 103 (9.8%) reported a history of TB, among whom 93% received anti-TB medication and 80% were diagnosed in the United States. Treatment was prematurely halted among 8% of patients; deportation from the United States was the cause of half of these treatment interruptions. History of travel to (odds ratio [OR] = 6.44; 95% confidence interval [CI] = 1.53, 27.20) or deportation from (OR = 1.83; 95% CI = 1.07, 3.12) the United States and incarceration (OR = 2.20; 95% CI = 1.06, 4.58) were independently associated with a reported lifetime diagnosis of TB. CONCLUSIONS Mobility and migration are important factors in identifying and treating TB patients diagnosed in the US-Mexico border region. Strengthening capacity on both sides of the border to identify, monitor, and treat TB is a priority.


Qualitative Health Research | 2012

Deportation Experiences of Women Who Inject Drugs in Tijuana, Mexico

Angela M. Robertson; Remedios Lozada; Alicia Vera; Lawrence A. Palinkas; Jose Luis Burgos; Carlos Magis-Rodriguez; Gudelia Rangel; Victoria D. Ojeda

Deportation from the United States for drug offenses is common, yet the consequences of deportation for women drug users are poorly documented. In 2008, in Tijuana, Mexico, we conducted an exploratory qualitative study of migration, deportation, and drug abuse by interviewing 12 Mexican injection-drug-using women reporting U.S. deportation. Women reported heavy drug use before and after deportation, but greater financial instability and physical danger following deportation than when in the United States. We identified an unmet need for health and social services among deported drug-using women, including HIV prevention, drug treatment, physical and mental health services, and vocational training. Binational coordination is needed to help deported women resettle in Mexico.


PLOS ONE | 2010

Cost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region.

Jose Luis Burgos; Julia A. Gaebler; Steffanie A. Strathdee; Remedios Lozada; Hugo Staines; Thomas L. Patterson

Background Previous research demonstrated efficacy of a brief behavioral intervention to reduce incidence of HIV and sexually transmitted infections (STIs) among female sex workers (FSWs) in Tijuana and Ciudad Juarez, Mexico, cities on Mexicos border with the US. We assessed this interventions cost-effectiveness. Methodology and Principal Findings A life-time Markov model was developed to estimate HIV cases prevented, changes in quality-adjusted life expectancy (QALE), and costs per additional quality-adjusted life year gained (QALY), comparing (in US


Journal of the International AIDS Society | 2015

Prevalence and correlates of HIV among men who have sex with men in Tijuana, Mexico

Eileen V. Pitpitan; David Goodman-Meza; Jose Luis Burgos; Daniela Abramovitz; Claudia V. Chavarin; Karla Torres; Steffanie A. Strathdee; Thomas L. Patterson

2,009) no intervention to a once-only and annual intervention. Future costs and health benefits were discounted annually at 3%. Sensitivity analyses evaluated model robustness. We found that for a hypothetical 1,000 FSWs receiving the once-only intervention, there were 33 HIV cases prevented and 5.7 months of QALE gained compared to no intervention. The additional cost per QALY gained was US


Global Public Health | 2012

HIV prevalence and sexual risk behaviour among non-injection drug users in Tijuana, Mexico

Robert Deiss; Remedios Lozada; Jose Luis Burgos; Steffanie A. Strathdee; Manuel Gallardo; Jazmine Cuevas; Richard S. Garfein

183. For FSWs receiving the intervention annually, there were 29 additional HIV cases prevented and 4.5 additional months of QALE compared to the once-only intervention. The additional cost per QALY was US


Journal of Immigrant and Minority Health | 2014

Establishing a binational student-run free-clinic in Tijuana, Mexico: a model for US-Mexico border states.

Victoria D. Ojeda; Amy Eppstein; Remedios Lozada; Adriana Vargas-Ojeda; Steffanie A. Strathdee; David Goodman; Jose Luis Burgos

1,075. When highly active antiretroviral therapy (HAART) was included in the model, the annual intervention strategy resulted in net savings and dominated both once-only and no intervention strategies, and remained robust across extensive sensitivity analyses. Even when considering clinical benefits from HAART, ignoring added costs, the cost per QALY gained remained below three times the Mexican GDP per capita, and below established cost-effectiveness thresholds. Conclusions/Significance This brief intervention was shown to be cost-effective among FSWs in two Mexico-US border cities and may have application for FSWs in other resource-limited settings. Trial Registration ClinicalTrials.gov NCT00338845


International Journal of Drug Policy | 2015

The role of visual markers in police victimization among structurally vulnerable persons in Tijuana, Mexico

Miguel Pinedo; Jose Luis Burgos; Adriana Vargas Ojeda; David Scott FitzGerald; Victoria D. Ojeda

Men who have sex with men (MSM) in developing countries such as Mexico have received relatively little research attention. In Tijuana, Mexico, a border city experiencing a dynamic HIV epidemic, data on MSM are over a decade old. Our aims were to estimate the prevalence and examine correlates of HIV infection among MSM in this city.


Global Public Health | 2014

Perceived risk of HIV infection among deported male injection drug users in Tijuana, Mexico

Miguel Pinedo; Jose Luis Burgos; Angela M. Robertson; Alicia Vera; Remedios Lozada; Victoria D. Ojeda

Abstract Prior studies estimate HIV prevalence of 4% among injection drug users (IDUs), compared with 0.8% in the general population of Tijuana, Mexico. However, data on HIV prevalence and correlates among non-injecting drug users (NIDUs) are sparse. Individuals were recruited through street outreach for HIV testing and behavioural risk assessment interviews to estimate HIV prevalence and identify associated sexual risk behaviours among NIDUs in Tijuana. Descriptive statistics were used to characterise ‘low-risk’ NIDUs (drug users who were not commercial sex workers or men who have sex with men). Results showed that HIV prevalence was 3.7% among low-risk NIDUs. During the prior six months, 52% of NIDUs reported having >1 casual partner; 35% reported always using condoms with a casual partner; and 13% and 15%, respectively, reported giving or receiving something in exchange for sex. Women were significantly more likely than men to have unprotected sex with an IDU (p<0.01). Conclusions: The finding that HIV prevalence among NIDUs was similar to that of IDUs suggests that HIV transmission has occurred outside of traditional core groups in Tijuana. Broad interventions including HIV testing, condom promotion and sexual risk reduction should be offered to all drug users in Tijuana.


Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2012

Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico

Michele G. Velasquez; Rafael Laniado-Laborín; Timothy C. Rodwell; Paris Cerecer; Remedios Lozada; Jazmine Cuevas-Mota; Jose Luis Burgos; Richard S. Garfein

In 2011, a bi-national student-run free clinic for the underserved, known as “Health Frontiers in Tijuana” (HFiT), was created in Tijuana, Mexico. Students and faculty from one Mexican and one US medical school staff the clinic and attend patients on Saturdays. Students from both medical schools enroll in a didactic course during the quarter/semester that they attend the free clinic. The course addresses clinical, ethical, cultural, population-specific issues and the structure, financing and delivery of medical care in Mexico. The clinic implements an electronic medical record and is developing telemedicine for consulting on complex cases. Despite challenges related to sustaining adequate funding, this program may be replicated in other border communities.

Collaboration


Dive into the Jose Luis Burgos's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Richard S. Garfein

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kathleen Moser

University of California

View shared research outputs
Top Co-Authors

Avatar

Miguel Pinedo

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kelly Collins

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge